Cell line name | AILNCaP |
---|---|
Synonyms | AI LNCaP; AI-LNCaP; Androgen-Independent LNCaP |
Accession | CVCL_U984 |
Resource Identification Initiative | To cite this cell line use: AILNCaP (RRID:CVCL_U984) |
Sequence variations | Homozygous for AR p.Thr878Ala (c.2632A>G) (ClinVar=VCV000009831) (from parent cell line).Heterozygous for MEN1 p.Tyr318Ter (c.954T>G) (p.Tyr313Ter; c.939T>A) (ClinVar=VCV000439894) (from parent cell line).Heterozygous for PIK3R1 p.Arg639Ter (c.1915C>T) (from parent cell line).PTEN p.Lys6Argfs*4 (c.17_18delAA) (ClinVar=VCV000231649) (from parent cell line). |
Disease | Prostate carcinoma (NCIt: C4863) Derived from metastatic site: Left supraclavicular lymph node. |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_1379 (LNCaP clone FGC) |
Sex of cell | Male |
Age at sampling | 50Y |
Category | Cancer cell line |
Publications | PubMed=16931574; DOI=10.1210/me.2006-0033 |
Cross-references | |
Ontologies | BTO; BTO:0004799 |
Other | Wikidata; Q54748998 |
Entry history | |
Entry creation | 16-Apr-2014 |
Last entry update | 29-Oct-2020 |
Version number | 11 |